Effective management of multidrug-resistant HIV with lenacapavir and fostemsavir: A case study
- PMID: 39484780
- DOI: 10.1177/09564624241296583
Effective management of multidrug-resistant HIV with lenacapavir and fostemsavir: A case study
Abstract
Resistance to antiretroviral therapy is an increasing challenge in the management of HIV. We present the case of a woman living with HIV, with a history of multiple treatment regimens and resistances to antiretrovirals, who has been successfully treated with a combination of lenacapavir and fostemsavir for the past year, obtaining an undetectable viral load within one month of starting therapy and reporting no serious side effects. This case is amongst the first to document the combined use of lenacapivir and fostemsavir in treating multidrug-resistant HIV. It supports the potential of these novel agents in managing complex cases of HIV resistance.
Keywords: ART (antiretroviral therapy); HIV (Human immunodeficiency virus); antiviral; other; treatment; viral disease.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous